Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
121.51
+1.07 (0.89%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Tenet Healthcare Market Cap
Tenet Healthcare has a market cap or net worth of $11.59 billion as of April 17, 2025. Its market cap has increased by 12.40% in one year.
Market Cap
11.59B
Enterprise Value
22.84B
1-Year Change
12.40%
Ranking
Category
Stock Price
$121.51
Market Cap Chart
Since December 1, 1998, Tenet Healthcare's market cap has increased from $9.27B to $11.59B, an increase of 24.99%. That is a compound annual growth rate of 0.85%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 17, 2025 | 11.59B | -3.48% |
Dec 31, 2024 | 12.00B | 56.42% |
Dec 29, 2023 | 7.67B | 45.48% |
Dec 30, 2022 | 5.28B | -39.72% |
Dec 31, 2021 | 8.75B | 107.70% |
Dec 31, 2020 | 4.21B | 6.64% |
Dec 31, 2019 | 3.95B | 124.90% |
Dec 31, 2018 | 1.76B | 14.81% |
Dec 29, 2017 | 1.53B | 3.49% |
Dec 30, 2016 | 1.48B | -51.04% |
Dec 31, 2015 | 3.02B | -39.36% |
Dec 31, 2014 | 4.98B | 19.15% |
Dec 31, 2013 | 4.18B | 20.89% |
Dec 31, 2012 | 3.46B | 55.16% |
Dec 30, 2011 | 2.23B | -31.40% |
Dec 31, 2010 | 3.25B | 25.25% |
Dec 31, 2009 | 2.59B | 372.63% |
Dec 31, 2008 | 548.70M | -77.22% |
Dec 31, 2007 | 2.41B | -26.69% |
Dec 29, 2006 | 3.29B | -8.64% |
Dec 30, 2005 | 3.60B | -29.83% |
Dec 31, 2004 | 5.12B | -31.31% |
Dec 31, 2003 | 7.46B | -6.73% |
Dec 31, 2002 | 8.00B | -58.15% |
Dec 31, 2001 | 19.11B | 35.64% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 754.27B |
UnitedHealth Group | 415.38B |
Johnson & Johnson | 379.48B |
AbbVie | 306.02B |
Novo Nordisk | 284.50B |
Abbott Laboratories | 227.16B |
Novartis AG | 209.93B |
AstraZeneca | 208.11B |